Skip to content
10-K

Annual Report

89bio, Inc.

0000950170-25-029243

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 145.98M sh
Shares Diluted FY 2024 · Dec 31, 2024 104.71M sh
Shares Diluted FY 2024 · Dec 31, 2023 71.17M sh
Shares Diluted FY 2024 · Dec 31, 2022 34.81M sh
Capex FY 2024 · Dec 31, 2024 $15K
Capex FY 2024 · Dec 31, 2023 $4K
Capex FY 2024 · Dec 31, 2022 $7K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$367.82M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$129.19M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$81.09M
Long Term Debt FY 2024 · Dec 31, 2024 $35.73M
Long Term Debt FY 2024 · Dec 31, 2023 $24.8M
Short Term Debt FY 2024 · Dec 31, 2024 $0
Cash And Equivalents FY 2024 · Dec 31, 2024 $126.06M
Cash And Equivalents FY 2024 · Dec 31, 2023 $316.16M
Stockholders Equity FY 2024 · Dec 31, 2024 $400.79M
Stockholders Equity FY 2024 · Dec 31, 2023 $536.31M
Stockholders Equity FY 2024 · Dec 31, 2022 $151.83M
Stockholders Equity FY 2024 · Dec 31, 2021 $125.96M
Current Liabilities FY 2024 · Dec 31, 2024 $36.13M
Current Liabilities FY 2024 · Dec 31, 2023 $29.61M
Total Liabilities FY 2024 · Dec 31, 2024 $77.9M
Total Liabilities FY 2024 · Dec 31, 2023 $59.96M
Current Assets FY 2024 · Dec 31, 2024 $476.45M
Current Assets FY 2024 · Dec 31, 2023 $593.53M
Total Assets FY 2024 · Dec 31, 2024 $478.69M
Total Assets FY 2024 · Dec 31, 2023 $596.27M
Eps Diluted FY 2024 · Dec 31, 2024 −$3.51
Eps Diluted FY 2024 · Dec 31, 2023 −$2.00
Eps Diluted FY 2024 · Dec 31, 2022 −$2.93
Eps Basic FY 2024 · Dec 31, 2024 −$3.51
Eps Basic FY 2024 · Dec 31, 2023 −$2.00
Eps Basic FY 2024 · Dec 31, 2022 −$2.93
Sga Expense FY 2024 · Dec 31, 2024 $39.62M
Sga Expense FY 2024 · Dec 31, 2023 $28.97M
Sga Expense FY 2024 · Dec 31, 2022 $21.45M
Rd Expense FY 2024 · Dec 31, 2024 $345.04M
Rd Expense FY 2024 · Dec 31, 2023 $122.23M
Rd Expense FY 2024 · Dec 31, 2022 $80.8M
Net Income FY 2024 · Dec 31, 2024 −$367.08M
Net Income FY 2024 · Dec 31, 2023 −$142.19M
Net Income FY 2024 · Dec 31, 2022 −$102.03M
Operating Income FY 2024 · Dec 31, 2024 −$384.66M
Operating Income FY 2024 · Dec 31, 2023 −$151.2M
Operating Income FY 2024 · Dec 31, 2022 −$102.25M